Department of Life Science, National Taiwan Normal University, Taipei 116, Taiwan.
Evid Based Complement Alternat Med. 2012;2012:276032. doi: 10.1155/2012/276032. Epub 2012 May 30.
Lung cancer has long been one of the most deadly forms of cancer. The majority of lung cancers are of the non-small-cell lung cancer (NSCLC) type. Here we used the non-small-cell lung carcinoma cell line A549 to screen 15 different traditional Chinese herbal medicine (CHM) formulae to explore the possible mechanisms of alternative medicine in lung cancer therapy. We identified three formulae (Formulae 3, 5, and 14) that substantially decreased the survival of A549 cells but did not affect MRC5 normal lung tissue cells. Formula 14, Yang-Dan-Tang, a modified decoction of Ramulus Cinnamomi Cassiae, was chosen for further characterization. Flow cytometry analysis showed that treatment of Formula 14 induced cell cycle arrest in G1 and G2 phase without causing significant cell death. These results were also confirmed by Western blot analysis, with decreased expression of G1/S and G2/M promoting cell cycle machinery including cyclin D3, cyclin B1, CDK4, and CDK6. This study provides further insight into the possible working mechanism of Yang-Dan-Tang in patients.
肺癌一直是最致命的癌症之一。大多数肺癌是非小细胞肺癌(NSCLC)。在这里,我们使用非小细胞肺癌细胞系 A549 筛选了 15 种不同的中药(CHM)配方,以探索替代医学在肺癌治疗中的可能机制。我们确定了三种配方(配方 3、5 和 14),它们大大降低了 A549 细胞的存活率,但对 MRC5 正常肺组织细胞没有影响。选择 14 号配方,阳旦汤,桂皮枝的改良煎剂,进一步进行表征。流式细胞术分析表明,14 号配方的处理诱导细胞周期停滞在 G1 和 G2 期,而不会导致明显的细胞死亡。Western blot 分析也证实了这一点,G1/S 和 G2/M 表达下降,促进了包括细胞周期蛋白 D3、细胞周期蛋白 B1、CDK4 和 CDK6 在内的细胞周期机制。这项研究为阳旦汤在患者中的可能作用机制提供了进一步的见解。